Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oz crop pty ltd - clopyralid present as the triisopropanolamine salt - soluble concentrate - clopyralid present as the triisopropanolamine salt pyridine active 300.0 g/l - herbicide - barley | canola | eucalyptus tree planting - post planting | fallow land | forest | industrial land or area | oats | pasture | p - broadleaf weeds - see label exceptions | californian thistle | cape ivy | capeweed | cat's ears or flatweeds | creeping/russian knapweed,hardhead | fleabane | groundsel bush | nodding thistle | prickly lettuce | ragwort | saffron thistle | scotch thistle | silver wattle | silver wattle - suppression | skeleton weed | slender, shore or sheep thistle | soldier thistle | sorrel - suppression | spear or black thistle | stemless thistle | thistle | variegated thistle | volunteer chickpea | volunteer faba bean | volunteer field pea | volunteer legume | volunteer lentil | volunteer lucerne - seedling | volunteer lupin | volunteer medic | volunteer safflower | volunteer subterranean clover | volunteer vetch or tares | annual flatweed | blessed thistle | bull thistle | cabbage thistle | canada thistle | carduus marianus | common lucerne | cotton thistle | creeping thistle | except dock | except pattersons curse | except shepherds purse | except some thistles | except sorrel | false star thistle | field pea | hardhead

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - butorphanol base as butorphanol tartrate - parenteral liquid/solution/suspension - butorphanol base as butorphanol tartrate alkaloid active 10.0 mg/ml - anaesthetics/analgesics - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - analgesic | sedative | antipyretic | colic | muscle relaxant | sedative | spasmolytic

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausrichter pty ltd - butorphanol base as butorphanol tartrate; benzethonium chloride - parenteral liquid/solution/suspension - butorphanol base as butorphanol tartrate alkaloid active 10.0 mg/ml; benzethonium chloride ammonium-quaternary other 0.1 mg/ml - analgesic+musculoskeletal - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - anaesthetic - local/general | analgesic | pre-anaesthetic | anaesthetic premedicant | antipyretic | colic | general anaesthetic | immobiliser | local anaesthetic | muscle relaxant | premedication | sedative | spasmolytic | tranquilliser | travel sickness

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 100ug (plus a 3% manufacturing overage); levothyroxine sodium 100ug (plus a 9% manufacturing overage) - tablet - 100 mcg - active: levothyroxine sodium 100ug (plus a 3% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc quinoline yellow sucrose sunset yellow aluminium lake active: levothyroxine sodium 100ug (plus a 9% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc quinoline yellow sucrose sunset yellow aluminium lake - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 112ug (plus a 3% manufacturing overage); levothyroxine sodium 112ug (plus a 9% manufacturing overage) - tablet - 112 mcg - active: levothyroxine sodium 112ug (plus a 3% manufacturing overage) excipient: acacia d&c red lake blend #9570 lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 112ug (plus a 9% manufacturing overage) excipient: acacia d&c red lake blend #9570 lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 125ug (plus a 3% manufacturing overage); levothyroxine sodium 125ug (plus a 9% manufacturing overage) - tablet - 125 mcg - active: levothyroxine sodium 125ug (plus a 3% manufacturing overage) excipient: acacia brown lake blend lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 125ug (plus a 9% manufacturing overage) excipient: acacia brown lake blend lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 137ug (plus a 9% manufacturing overage); levothyroxine sodium 137ug (plus a 3% manufacturing overage) - tablet - 137 mcg - active: levothyroxine sodium 137ug (plus a 9% manufacturing overage) excipient: acacia brilliant blue fcf lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 137ug (plus a 3% manufacturing overage) excipient: acacia brilliant blue fcf lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 150ug (plus a 9% manufacturing overage); levothyroxine sodium 150ug (plus a 2% manufacturing overage) - tablet - 150 mcg - active: levothyroxine sodium 150ug (plus a 9% manufacturing overage) excipient: acacia indigo carmine lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 150ug (plus a 2% manufacturing overage) excipient: acacia indigo carmine lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 175ug (plus a 9% manufacturing overage); levothyroxine sodium 175ug (plus a 2% manufacturing overage) - tablet - 175 mcg - active: levothyroxine sodium 175ug (plus a 9% manufacturing overage) excipient: acacia brilliant blue fcf d&c red lake blend #9570 lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 175ug (plus a 2% manufacturing overage) excipient: acacia brilliant blue fcf d&c red lake blend #9570 lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 200ug (plus a 9% manufacturing overage); levothyroxine sodium 200ug (plus a 2% manufacturing overage) - tablet - 200 mcg - active: levothyroxine sodium 200ug (plus a 9% manufacturing overage) excipient: acacia allura red ac lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 200ug (plus a 2% manufacturing overage) excipient: acacia allura red ac lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.